Pages that link to "Q26864234"

The following pages link to Selection of induction therapy in kidney transplantation (Q26864234):

Displaying 22 items.

• Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study (Q34027642) (← links)
• Near-term anti-CD25 monoclonal antibody administration protects murine liver from ischemia-reperfusion injury due to reduced numbers of CD4 T cells (Q34134224) (← links)
• Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance (Q35682221) (← links)
• A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology (Q35805955) (← links)
• Mesenchymal stromal cells inhibit CD25 expression via the mTOR pathway to potentiate T-cell suppression (Q37745268) (← links)
• Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients (Q38706959) (← links)
• Effectiveness of an Evidence-Based Induction Therapy Protocol Revision in Adult Kidney Transplant Recipients (Q38802439) (← links)
• Unintended Immunological Consequences of Biologic Therapy. (Q38871098) (← links)
• Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation (Q38892578) (← links)
• Profiling risk for acute rejection in kidney transplantation: recipient age is a robust risk factor. (Q39338311) (← links)
• Cost-Effectiveness of Antibody-Based Induction Therapy in Deceased Donor Kidney Transplantation in the United States (Q39630797) (← links)
• Immunosuppression and its use in kidney transplantation (Q40956126) (← links)
• Acute Rejection Rates and Graft Outcomes According to Induction Regimen among Recipients of Kidneys from Deceased Donors Treated with Tacrolimus and Mycophenolate (Q41022599) (← links)
• Rapidly growing non-tuberculous mycobacterial infection in a renal transplant patient after alemtuzumab induction. (Q42205422) (← links)
• Analysis of Risk Factors for Kidney Retransplant Outcomes Associated with Common Induction Regimens: A Study of over Twelve-Thousand Cases in the United States. (Q47193453) (← links)
• Impact of Induction Therapy on Delayed Graft Function Following Kidney Transplantation in Mated Kidneys (Q47965297) (← links)
• Tailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation (Q49724077) (← links)
• Induction of suppressive allogeneic regulatory T cells via rabbit antithymocyte polyclonal globulin during homeostatic proliferation in rat kidney transplantation. (Q50781725) (← links)
• Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study (Q64059804) (← links)
• Targeting Regulatory T Cells for Transplant Tolerance: New Insights and Future Perspectives (Q90685929) (← links)
• Reconstitution of T-Cell Subsets Following Thymoglobulin-Induced Depletion in High Immunologic Risk and Donation After Cardiac Death Renal Transplant Recipients (Q92531701) (← links)
• Effectiveness of Thymoglobulin Induction Therapy in Kidney Transplant From Deceased Donor With Mild to Moderate Acute Kidney Injury (Q93044156) (← links)